Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect

Stéphane Auroy, Marie Françoise Avril, Agnès Chompret, Danièle Pham, Alisa M. Goldstein, Giovanna Bianchi-Scarrà, Thierry Frebourg, Pascal Joly, Alain Spatz, Carole Rubino, Florence Demenais, Brigitte Bressac De Paillerets

Research output: Contribution to journalArticlepeer-review

Abstract

Multiple primary cancers are one of the hallmarks of inherited predisposition. Outside the familial context, multiple primary tumors could be related either to germline de novo mutations or to low-penetrance mutations, in predisposing genes. We selected 100 patients who displayed multiple primary melanoma (MPM) without any known melanoma cases recorded within their families and looked for germline mutations in the two melanoma-predisposing genes identified to date, CDKN2A and CDK4 exon 2. Nine patients (9%) had germline mutations in CDKN2A, whereas none carried germline mutations in exon 2 of CDK4. Seven cases displayed a recurrent missense mutation, G101W, already described in more than 20 melanoma-prone families; one case carried a missense mutation never reported to date (P114S), and the last case was a carrier of a 6 bp insertion at nucleotide 57 resulting in a duplication of codons 18 and 19. To ascertain whether the G101W was a mutational hot spot for de novo mutations or a common founder mutation, we genotyped eight microsatellite markers flanking the CDKN2A gene. After allowing for recombination over time, haplotype sharing provided evidence for an original G101W mutation common to 6 out of 7 sporadic MPM cases. Therefore, it can be concluded that de novo germline CDKN2A mutations associated with MPM are rare.

Original languageEnglish
Pages (from-to)195-202
Number of pages8
JournalGenes Chromosomes and Cancer
Volume32
Issue number3
DOIs
Publication statusPublished - 2001

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Fingerprint Dive into the research topics of 'Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect'. Together they form a unique fingerprint.

Cite this